<unk>  is an antineoplastic agent that is FDA approved for the treatment of patients with evidence of axillary node tumor involvement following resection of primary breast cancer. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include alopecia , flushing , itching, rash, diarrhea , nausea and vomiting, anemia , leukopenia,neutropenia,  thrombocytopenia ,lethargy ,conjunctivitis, keratitis ,amenorrhea.
Epirubicin
Pirarubicin
Amrubicin
Aclarubicin
Valrubicin
Zorubicin
Ifosfamide
Mitomycin 